Last reviewed · How we verify
Diphenhydramine 25mg
At a glance
| Generic name | Diphenhydramine 25mg |
|---|---|
| Sponsor | Montefiore Medical Center |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Trial of Diphenhydramine for Sleep in Children With Autism (PHASE2)
- Comparing Digital Therapy, Trazodone, and Daridorexant for Menopause-Related Insomnia Symptoms (PHASE4)
- E7 TCR T Cells for Human Papillomavirus-Associated Cancers (PHASE1, PHASE2)
- Sunitinib or Cediranib for Alveolar Soft Part Sarcoma (PHASE2)
- Study to Use Oral Losartan to Decrease the Risk of Postoperative Scarring Following (ACL) Reconstruction (PHASE4)
- Mezigdomide and Elranatamab for Relapsed and/or Refractory Multiple Myeloma (PHASE1, PHASE2)
- Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma (PHASE2)
- Haldol/Diphenhydramine Versus Metoclopramide/Diphenhydramine for Treatment of Acute Headache in the ED: A RCT (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Diphenhydramine 25mg CI brief — competitive landscape report
- Diphenhydramine 25mg updates RSS · CI watch RSS
- Montefiore Medical Center portfolio CI